Peptides and Autoimmune Diseases

Several self-molecules have been identified as target antigens in autoimmune diseases. Since lack or loss of tolerance to these molecules is one of the key events promoting autoimmunity, researchers are exploring the possibility that the administration of antigens or peptides may stimulate tolerogenic mechanisms and delay or prevent the full phenotypic expression of autoimmune diseases. 

 

 

<div style="&quot;text-align:" justify;"="">

 

 

 

 

 

 

 

 

 

  • Thymus
  • Harnessing Treg cells
  • Designing Peptides for Therapy

Related Conference of Peptides and Autoimmune Diseases

November 21-22, 2019

World Conference on Vaccine and Immunology

MENA Plaza Hotel Albarsha | Dubai, UAE
November 21-22, 2019

14th International Conference on Allergy and Clinical Immunology

Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
December 02-03, 2019

10th International Conference on Immunology & Immunogenetics

Park Inn by Radisson Hotel & Conference Centre London
June 23-24, 2020

34th World Congress on Vaccines and Immunization

Osaka, Japan
September 14-15, 2020

35th World Congress on Immunology

Tokyo, Japan
Oct 12-13, 2020

International Conference on Vaccine and Vaccine Research

Manila, Philippines
October 14-15, 2020

13th International Conference on Allergy & Immunology

Zurich, Switzerland
October 19-20, 2020

lifestylemanagment-cs-2020

Amsterdam, Netherlands

International Conference on Immunology & Immunotherapies

November 18-19, 2020 | Bangkok, Thailand
November 25-26, 2020

International Conference On European Immunology

London, UK

Peptides and Autoimmune Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in